Your browser doesn't support javascript.
loading
Interpreting the CYP2D6 results from the International Tamoxifen Pharmacogenetics Consortium.
Province, M A; Altman, R B; Klein, T E.
Affiliation
  • Province MA; Division of Statistical Genomics, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Altman RB; Department of Genetics, Stanford University, Stanford, California, USA.
  • Klein TE; Department of Genetics, Stanford University, Stanford, California, USA.
Clin Pharmacol Ther ; 96(2): 144-6, 2014 Aug.
Article in En | MEDLINE | ID: mdl-25056393
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics / Tamoxifen / Breast Neoplasms / Congresses as Topic / Antineoplastic Agents, Hormonal / Cytochrome P-450 CYP2D6 Limits: Female / Humans Language: En Journal: Clin Pharmacol Ther Year: 2014 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics / Tamoxifen / Breast Neoplasms / Congresses as Topic / Antineoplastic Agents, Hormonal / Cytochrome P-450 CYP2D6 Limits: Female / Humans Language: En Journal: Clin Pharmacol Ther Year: 2014 Document type: Article Affiliation country: United States